Buckwheat
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Bronchopulmonary Dysplasia Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Surfactant Replacement Therapy
1.2.3 Oxygen Therapy
1.2.4 Supportive Therapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bronchopulmonary Dysplasia Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bronchopulmonary Dysplasia Market Perspective (2017-2028)
2.2 Bronchopulmonary Dysplasia Growth Trends by Region
2.2.1 Bronchopulmonary Dysplasia Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Bronchopulmonary Dysplasia Historic Market Size by Region (2017-2022)
2.2.3 Bronchopulmonary Dysplasia Forecasted Market Size by Region (2023-2028)
2.3 Bronchopulmonary Dysplasia Market Dynamics
2.3.1 Bronchopulmonary Dysplasia Industry Trends
2.3.2 Bronchopulmonary Dysplasia Market Drivers
2.3.3 Bronchopulmonary Dysplasia Market Challenges
2.3.4 Bronchopulmonary Dysplasia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bronchopulmonary Dysplasia Players by Revenue
3.1.1 Global Top Bronchopulmonary Dysplasia Players by Revenue (2017-2022)
3.1.2 Global Bronchopulmonary Dysplasia Revenue Market Share by Players (2017-2022)
3.2 Global Bronchopulmonary Dysplasia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bronchopulmonary Dysplasia Revenue
3.4 Global Bronchopulmonary Dysplasia Market Concentration Ratio
3.4.1 Global Bronchopulmonary Dysplasia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bronchopulmonary Dysplasia Revenue in 2021
3.5 Bronchopulmonary Dysplasia Key Players Head office and Area Served
3.6 Key Players Bronchopulmonary Dysplasia Product Solution and Service
3.7 Date of Enter into Bronchopulmonary Dysplasia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bronchopulmonary Dysplasia Breakdown Data by Type
4.1 Global Bronchopulmonary Dysplasia Historic Market Size by Type (2017-2022)
4.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2023-2028)
5 Bronchopulmonary Dysplasia Breakdown Data by Application
5.1 Global Bronchopulmonary Dysplasia Historic Market Size by Application (2017-2022)
5.2 Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bronchopulmonary Dysplasia Market Size (2017-2028)
6.2 North America Bronchopulmonary Dysplasia Market Size by Country (2017-2022)
6.3 North America Bronchopulmonary Dysplasia Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Bronchopulmonary Dysplasia Market Size (2017-2028)
7.2 Europe Bronchopulmonary Dysplasia Market Size by Country (2017-2022)
7.3 Europe Bronchopulmonary Dysplasia Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bronchopulmonary Dysplasia Market Size (2017-2028)
8.2 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Country (2017-2022)
8.3 Asia-Pacific Bronchopulmonary Dysplasia Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Bronchopulmonary Dysplasia Market Size (2017-2028)
9.2 Latin America Bronchopulmonary Dysplasia Market Size by Country (2017-2022)
9.3 Latin America Bronchopulmonary Dysplasia Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bronchopulmonary Dysplasia Market Size (2017-2028)
10.2 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2017-2022)
10.3 Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Detail
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Bronchopulmonary Dysplasia Introduction
11.1.4 Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2017-2022)
11.1.5 Chiesi Farmaceutici Recent Development
11.2 Discovery Laboratories
11.2.1 Discovery Laboratories Company Detail
11.2.2 Discovery Laboratories Business Overview
11.2.3 Discovery Laboratories Bronchopulmonary Dysplasia Introduction
11.2.4 Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2017-2022)
11.2.5 Discovery Laboratories Recent Development
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Company Detail
11.3.2 Takeda Pharmaceutical Company Business Overview
11.3.3 Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Introduction
11.3.4 Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2017-2022)
11.3.5 Takeda Pharmaceutical Company Recent Development
11.4 MediPost
11.4.1 MediPost Company Detail
11.4.2 MediPost Business Overview
11.4.3 MediPost Bronchopulmonary Dysplasia Introduction
11.4.4 MediPost Revenue in Bronchopulmonary Dysplasia Business (2017-2022)
11.4.5 MediPost Recent Development
11.5 Clarassance
11.5.1 Clarassance Company Detail
11.5.2 Clarassance Business Overview
11.5.3 Clarassance Bronchopulmonary Dysplasia Introduction
11.5.4 Clarassance Revenue in Bronchopulmonary Dysplasia Business (2017-2022)
11.5.5 Clarassance Recent Development
11.6 Syntrix Biosystems
11.6.1 Syntrix Biosystems Company Detail
11.6.2 Syntrix Biosystems Business Overview
11.6.3 Syntrix Biosystems Bronchopulmonary Dysplasia Introduction
11.6.4 Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2017-2022)
11.6.5 Syntrix Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Surfactant Replacement Therapy
Table 3. Key Players of Oxygen Therapy
Table 4. Key Players of Supportive Therapy
Table 5. Key Players of Others
Table 6. Global Bronchopulmonary Dysplasia Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Bronchopulmonary Dysplasia Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Bronchopulmonary Dysplasia Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Bronchopulmonary Dysplasia Market Share by Region (2017-2022)
Table 10. Global Bronchopulmonary Dysplasia Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Bronchopulmonary Dysplasia Market Share by Region (2023-2028)
Table 12. Bronchopulmonary Dysplasia Market Trends
Table 13. Bronchopulmonary Dysplasia Market Drivers
Table 14. Bronchopulmonary Dysplasia Market Challenges
Table 15. Bronchopulmonary Dysplasia Market Restraints
Table 16. Global Bronchopulmonary Dysplasia Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Bronchopulmonary Dysplasia Market Share by Players (2017-2022)
Table 18. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchopulmonary Dysplasia as of 2021)
Table 19. Ranking of Global Top Bronchopulmonary Dysplasia Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Bronchopulmonary Dysplasia Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bronchopulmonary Dysplasia Product Solution and Service
Table 23. Date of Enter into Bronchopulmonary Dysplasia Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bronchopulmonary Dysplasia Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2017-2022)
Table 27. Global Bronchopulmonary Dysplasia Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Bronchopulmonary Dysplasia Revenue Market Share by Type (2023-2028)
Table 29. Global Bronchopulmonary Dysplasia Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Bronchopulmonary Dysplasia Revenue Market Share by Application (2017-2022)
Table 31. Global Bronchopulmonary Dysplasia Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Bronchopulmonary Dysplasia Revenue Market Share by Application (2023-2028)
Table 33. North America Bronchopulmonary Dysplasia Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Bronchopulmonary Dysplasia Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Bronchopulmonary Dysplasia Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Bronchopulmonary Dysplasia Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Bronchopulmonary Dysplasia Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Bronchopulmonary Dysplasia Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Bronchopulmonary Dysplasia Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Bronchopulmonary Dysplasia Market Size by Country (2023-2028) & (US$ Million)
Table 43. Chiesi Farmaceutici Company Detail
Table 44. Chiesi Farmaceutici Business Overview
Table 45. Chiesi Farmaceutici Bronchopulmonary Dysplasia Product
Table 46. Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2017-2022) & (US$ Million)
Table 47. Chiesi Farmaceutici Recent Development
Table 48. Discovery Laboratories Company Detail
Table 49. Discovery Laboratories Business Overview
Table 50. Discovery Laboratories Bronchopulmonary Dysplasia Product
Table 51. Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2017-2022) & (US$ Million)
Table 52. Discovery Laboratories Recent Development
Table 53. Takeda Pharmaceutical Company Company Detail
Table 54. Takeda Pharmaceutical Company Business Overview
Table 55. Takeda Pharmaceutical Company Bronchopulmonary Dysplasia Product
Table 56. Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2017-2022) & (US$ Million)
Table 57. Takeda Pharmaceutical Company Recent Development
Table 58. MediPost Company Detail
Table 59. MediPost Business Overview
Table 60. MediPost Bronchopulmonary Dysplasia Product
Table 61. MediPost Revenue in Bronchopulmonary Dysplasia Business (2017-2022) & (US$ Million)
Table 62. MediPost Recent Development
Table 63. Clarassance Company Detail
Table 64. Clarassance Business Overview
Table 65. Clarassance Bronchopulmonary Dysplasia Product
Table 66. Clarassance Revenue in Bronchopulmonary Dysplasia Business (2017-2022) & (US$ Million)
Table 67. Clarassance Recent Development
Table 68. Syntrix Biosystems Company Detail
Table 69. Syntrix Biosystems Business Overview
Table 70. Syntrix Biosystems Bronchopulmonary Dysplasia Product
Table 71. Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2017-2022) & (US$ Million)
Table 72. Syntrix Biosystems Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bronchopulmonary Dysplasia Market Share by Type: 2021 VS 2028
Figure 2. Surfactant Replacement Therapy Features
Figure 3. Oxygen Therapy Features
Figure 4. Supportive Therapy Features
Figure 5. Others Features
Figure 6. Global Bronchopulmonary Dysplasia Market Share by Application in 2021 & 2028
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Others Case Studies
Figure 10. Bronchopulmonary Dysplasia Report Years Considered
Figure 11. Global Bronchopulmonary Dysplasia Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Bronchopulmonary Dysplasia Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Bronchopulmonary Dysplasia Market Share by Region: 2021 VS 2028
Figure 14. Global Bronchopulmonary Dysplasia Market Share by Players in 2021
Figure 15. Global Top Bronchopulmonary Dysplasia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bronchopulmonary Dysplasia as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Bronchopulmonary Dysplasia Revenue in 2021
Figure 17. North America Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Bronchopulmonary Dysplasia Market Share by Country (2017-2028)
Figure 19. United States Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Bronchopulmonary Dysplasia Market Share by Country (2017-2028)
Figure 23. Germany Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Bronchopulmonary Dysplasia Market Share by Region (2017-2028)
Figure 31. China Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Bronchopulmonary Dysplasia Market Share by Country (2017-2028)
Figure 39. Mexico Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Bronchopulmonary Dysplasia Market Share by Country (2017-2028)
Figure 43. Turkey Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Bronchopulmonary Dysplasia Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Chiesi Farmaceutici Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2017-2022)
Figure 46. Discovery Laboratories Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2017-2022)
Figure 47. Takeda Pharmaceutical Company Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2017-2022)
Figure 48. MediPost Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2017-2022)
Figure 49. Clarassance Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2017-2022)
Figure 50. Syntrix Biosystems Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2017-2022)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Chiesi Farmaceutici Discovery Laboratories Takeda Pharmaceutical Company MediPost Clarassance Syntrix Biosystems